Colorectal Cancer Screening Market, By Screening Tests (Stool-based Tests, Colonoscopy, CT Colonography , Flexible Sigmoidoscopy, Others), By End User (Hospitals, Specialty Clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024

Code : CMI5098

Pages :181

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Market Concentration and Competitive Landscape

Colorectal Cancer Screening Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Demand for Colorectal Cancer Screening Tests

Increasing demand for colorectal cancer screening tests is expected to drive the global colorectal cancer screening market growth over the forecast period. For instance, in May 2022, Guardant Health, Inc., a healthcare company, announced the availability of Shield, the company’s first blood-based test for the detection of early-stage colorectal cancer. The test is intended for adults aged 45 years and older and those who are not up to date with recommended screening guidelines, show no symptoms, and are at average risk for colorectal cancer.

Key Players Insights